These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 6813636)

  • 21. Gradual recovery of lactotroph responsiveness to dynamic stimulation following surgical removal of prolactinomas: long-term follow-up studies.
    Arafah BM; Brodkey JS; Pearson OH
    Metabolism; 1986 Oct; 35(10):905-12. PubMed ID: 3093797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of GnRH-associated peptide on prolactin secretion from human lactotrope adenoma cells in culture.
    Ishibashi M; Yamaji T; Takaku F; Teramoto A; Fukushima T; Toyama M; Kamoi K
    Acta Endocrinol (Copenh); 1987 Sep; 116(1):81-4. PubMed ID: 3310494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical cure of prolactinoma reverses abnormal prolactin repsonse to carbidopa/L-dopa.
    Molitch ME; Goodman RH; Post KD; Biller BJ; Moses AC; King LW; Feldman ZT; Reichlin S
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1118-23. PubMed ID: 7130339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbidopa plus L-dopa pretreatment inhibits the prolactin (PRL) response to thyrotropin-releasing hormone and thus cannot distinguish central from pituitary sites of prolactin stimulation.
    Carlson HE
    J Clin Endocrinol Metab; 1986 Jul; 63(1):249-51. PubMed ID: 3086358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolactin response to thyrotropin-releasing hormone (TRH) in patients with hypothalamic-pituitary disease.
    Barbieri RL; Cooper DS; Daniels GH; Nathan D; Klibanski A; Ridgway EC
    Fertil Steril; 1985 Jan; 43(1):66-73. PubMed ID: 3917409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of hypothalamic dopaminergic function in patients with pituitary prolactinoma.
    Xia P; Shi YF
    Proc Chin Acad Med Sci Peking Union Med Coll; 1989; 4(3):121-5. PubMed ID: 2594732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistence of impaired PRL responses to sulpiride in patients with PRL secreting pituitary adenomas after successful hypophysectomy.
    Hanew K; Sasaki A; Sato S; Kasai M; Murata K; Shimizu Y; Murakami O; Yoshinaga K
    Tohoku J Exp Med; 1983 Jul; 140(3):225-33. PubMed ID: 6414103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolactin secretion from human prolactinomas perifused in vitro: effect of TRH, prostaglandin E1, theophylline, dopamine and dopamine receptor blockers.
    Chihara K; Iwasaki J; Minamitani N; Kaji H; Kodama H; Fujita T; Shirataki K; Tamaki N; Matsumoto S
    Acta Endocrinol (Copenh); 1984 Jan; 105(1):6-13. PubMed ID: 6421041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of thyrotropin-releasing hormone in distinguishing prolactin-secreting pituitary adenoma.
    Marrs RP; Bertolli SJ; Kletzky OA
    Am J Obstet Gynecol; 1980 Nov; 138(6):620-5. PubMed ID: 6776812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoamine regulation of prolactin and TSH secretion in hypothyroidism.
    Gerasimov G; Chernova T; Goncharov N
    Acta Med Austriaca; 1992; 19 Suppl 1():86-8. PubMed ID: 1519463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term bromocriptine therapy may restore the inhibitory control of prolactin release in some patients with pathological hyperprolactinemia.
    Ho KY; Smythe GA; Compton PJ; Lazarus L
    Aust N Z J Med; 1985 Apr; 15(2):213-9. PubMed ID: 3927887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The preoperative and postoperative investigation of TSH and prolactin release in the management of patients with hyperprolactinaemia due to prolactinomas and nonfunctional pituitary tumours: relationship to adenoma size at surgery.
    Scanlon MF; Peters JR; Salvador J; Richards SH; John R; Howell S; Williams ED; Thomas JP; Hall R
    Clin Endocrinol (Oxf); 1986 Apr; 24(4):435-46. PubMed ID: 3091297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolactin dynamics and tumour size in the prediction of surgical outcome for prolactinoma.
    Gordon D; Richards A; Bulloch R; Cohen HN; Semple CG; Beastall GH; Thomson JA; Teasdale G
    Q J Med; 1985 Feb; 54(214):141-51. PubMed ID: 3920723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
    Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
    J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrity of central dopaminergic system in women with postpartum hyperprolactinemia.
    Rao R; Scommegna A; Frohman LA
    Am J Obstet Gynecol; 1982 Aug; 143(8):883-7. PubMed ID: 7102764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for increased dopaminergic inhibition of secretion of thyroid-stimulating hormone in hyperprolactinemic patients with pituitary microadenoma.
    Quigley ME; Yen SS
    Am J Obstet Gynecol; 1980 Jul; 137(6):653-5. PubMed ID: 7395929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transsphenoidal adenomectomy for GH-, PRL- and ACTH-secreting pituitary tumours: outcome analysis in a series of 125 patients.
    Esposito V; Santoro A; Minniti G; Salvati M; Innocenzi G; Lanzetta G; Cantore G
    Neurol Sci; 2004 Dec; 25(5):251-6. PubMed ID: 15624082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The diagnostic value of pharmacodynamic tests in the hyperprolactinaemic syndrome.
    Ayalon D; Persitz E; Ravid R; Jedwab G; Avidan S; Cordova T; Harell A
    Clin Endocrinol (Oxf); 1979; 11(2):201-15. PubMed ID: 114343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of the thyrotropin-releasing hormone test in patients with prolactin-secreting pituitary tumors and suprasellar non-pituitary tumors.
    Klijn JG; Lamberts SW; de Jong FH; Birkenhäger JC
    Fertil Steril; 1981 Feb; 35(2):155-61. PubMed ID: 6781936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Catecholamines and pituitary function. III. Restoration of the prolactin response to thyrotropin-releasing hormone by low-dose dopamine infusion in women with pathological hyperprolactinemia.
    Nicoletti I; Filipponi P; Fedeli L; Sfrappini M; Gregorini G; Ambrosi F; Santeusanio F
    Horm Res; 1984; 20(3):202-12. PubMed ID: 6436160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.